MTIM
NGA.WS

Marathon Trading Investment Management’s Northern Genesis Acquisition Corp. Redeemable Warrants, each warrant exercisable for shares of commo NGA.WS Stock Holding History

Marathon Trading Investment Management’s Portfolio NGA.WS Stock Details NGA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-108,300
Closed -$644K – 468
2021
Q1 		$644K Buy
+108,300
New +$874K 0.06% 177

Marathon Trading Investment Management's NGA.WS Position: Q2 2021 in Review

Marathon Trading Investment Management sold out of Northern Genesis Acquisition Corp. Redeemable Warrants, each warrant exercisable for shares of commo (NGA.WS) in Q2 2021, closing a stake of 108,300 shares — an estimated $644K sold.

Marathon Trading Investment Management first reported a position in NGA.WS in Q1 2021 and held it in 1 quarter. The position peaked at $644K in Q1 2021. 0 funds tracked by Wall St. Rank hold NGA.WS as of Q2 2021.

  • Marathon Trading Investment Management reported no remaining Northern Genesis Acquisition Corp. Redeemable Warrants, each warrant exercisable for shares of commo position as of Q2 2021 after selling out during the quarter.
  • Marathon Trading Investment Management sold 108,300 Northern Genesis Acquisition Corp. Redeemable Warrants, each warrant exercisable for shares of commo shares in Q2 2021, an estimated $644K.
  • Marathon Trading Investment Management first reported a position in Northern Genesis Acquisition Corp. Redeemable Warrants, each warrant exercisable for shares of commo in Q1 2021 and held it in 1 quarter.
  • Marathon Trading Investment Management's Northern Genesis Acquisition Corp. Redeemable Warrants, each warrant exercisable for shares of commo position peaked at $644K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Northern Genesis Acquisition Corp. Redeemable Warrants, each warrant exercisable for shares of commo as of Q2 2021.

Based on Marathon Trading Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.